Table 1 Characteristics of all patients alive 1 year after oesophageal cancer diagnosis
| Â | Curative intent | Palliative intent | ||
|---|---|---|---|---|
HRQOLa data | HRQOLa data | |||
Yes | No | Yes | No | |
Responders: | ||||
 Total | 884 | 709 | 267 | 411 |
 Sex ratio (M: F) | 683:201 | 559:150 | 193:74 | 299:112 |
 Age (years) | 66 (29–93) | 65 (20–89) | 72 (37–91) | 70 (21–95) |
WHO performance status | 867 | 689 | 260 | 398 |
 0 | 493 (57) | 406 (59) | 69 (26) | 124 (31) |
 1 | 327 (38) | 212 (31) | 121 (47) | 153 (38) |
 2 | 44 (5) | 65 (9) | 56 (22) | 87 (22) |
 3 | 3 (0) | 6 (1) | 13 (5) | 32 (8) |
 4 | 0 (0) | 0 (0) | 1 (0) | 2 (0) |
 Missing | 17 | 20 | 7 | 13 |
ASA comorbidity score | 871 | 697 | 259 | 400 |
 1 | 297 (34) | 236 (34) | 49 (19) | 75 (19) |
 2 | 443 (51) | 338 (49) | 107 (41) | 163 (40) |
 3 | 126 (14) | 114 (16) | 86 (33) | 143 (36) |
 4 | 5 (1) | 9 (1) | 17 (7) | 19 (5) |
 Missing | 13 | 12 | 8 | 11 |
Tumor location | ||||
 Proximal | 53 (6) | 45 (6) | 14 (6) | 33 (8) |
 Middle | 81 (9) | 78 (11) | 25 (11) | 45 (11) |
 Distal | 643 (73) | 502 (71) | 169 (73) | 237 (58) |
 Not specified | 107 (12) | 82 (12) | 24 (10) | 95 (23) |
Histological type | 878 | 701 | 265 | 410 |
 Adenocarcinom | 614 (70) | 464 (66) | 175 (66) | 260 (63) |
 SCCb | 191 (22) | 175 (25) | 59 (22) | 102 (25) |
 Other | 73 (8) | 62 (9) | 31 (12) | 48 (12) |
Clinical T stage | 884 | 708 | 267 | 410 |
 T0-T1 | 145 (16) | 132 (19) | 40 (15) | 46 (11) |
 T2–3 | 595 (67) | 466 (65) | 138 (52) | 224 (55) |
 T4 | 36 (4) | 54 (8) | 38 (14) | 69 (17) |
 Tx | 108 (12) | 56 (8) | 51 (19) | 71 (17) |
Clinical N stage | 884 | 708 | 267 | 410 |
 N0 | 529 (60) | 382 (54) | 104 (39) | 136 (33) |
  > N1 | 322 (36) | 291 (41) | 134 (50) | 213 (52) |
 Nx | 33 (4) | 35 (5) | 29 (11) | 61 (15) |
Clinical M stage | 883 | 707 | 267 | 406 |
 M0 | 851 (96) | 673 (95) | 155 (58) | 214 (53) |
 M1 | 16 (2) | 19 (3) | 110 (41) | 181 (44) |
 Mx | 16 (2) | 15 (2) | 2 (1) | 11 (3) |